Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carrie A. Coutant"'
Publikováno v:
Dissolution Technologies. 30:6-11
Autor:
James Mann, Andre Hermans, Nathan Contrella, Beverly Nickerson, Carrie A. Coutant, Christian Jede, Shangming Kao, Dawen Kou, Emmanuel Scheubel, Fredrik Winge, Johanna Milsmann, Martin Mueller-Zsigmondy, Nikolay Zaborenko
Publikováno v:
Dissolution Technologies. 29:190-203
Autor:
Andre Hermans, Lawrence X. Yu, Johannes Krämer, Kimberly Raines, Carrie A. Coutant, Michael J. Cohen, David Curran, Limin Zhang, Jesse Kuiper, Sandra Suarez-Sharp, German Drazer, Yiqing Lin, Xujin Lu, Erika S. Stippler, Sarah Pope-Miksinski, Andreas Abend, Hanlin Li, Haiyan Grady, Pramod Kotwal, Dorys Argelia Diaz
Publikováno v:
The AAPS journal. 21(2)
This publication summarizes the proceedings and key outcomes of the first day (“Day 1”) of the 3-day workshop on “Dissolution and Translational Modeling Strategies Enabling Patient-Centric Product Development.” The overall aims of the worksho
Autor:
Andre Hermans, Andreas Abend, Limin Zhang, Dorys Argelia Diaz, Talia Flanagan, Gregory K. Webster, Haiyan Grady, Filippos Kesisoglou, Michael J. Cohen, David A. Hahn, Carrie A. Coutant, Yiqing Lin, Yun Mao
Publikováno v:
The AAPS journal. 19(6)
This manuscript represents the perspective of the Dissolution Analytical Working Group of the IQ Consortium. The intent of this manuscript is to highlight the challenges of, and to provide a recommendation on, the development of clinically relevant d
Publikováno v:
Molecular Pharmaceutics. 7:1508-1515
Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An example is presented of an immediate release drug product which underwent changes to both rel
Publikováno v:
The AAPS journal. 17(6)
Effective integration of in vitro tests and absorption modeling can greatly improve our capability in understanding, comparing, and predicting in vivo performances of clinical drug products. In this case, we used a proprietary drug candidate galunise